The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
1996-02
Metadata
Show full item recordCitation
Dementia. 1996, 7(1):47-52Abstract
Eighteen patients with probable Alzheimer's disease (NINCDS/ADRDA criteria) participated in a placebo-controlled, double-blind study, with a crossover design. The patients had mild or moderate dementia (MMSE = 20.3 +/- 4.6, range 12-28). The trial consisted of two 4-week periods with a 2-week washout period in between. Nicotine was given in the form of dermal plasters. Most of the patients tolerated the highest doses of 21 mg nicotine/24 h, but some received 14 mg/24 h. The effect was monitored with tests of short-term memory, verbal fluency, attention and psychomotor speed. Nicotine was also determined in the blood. Short-term memory improved significantly after 4 weeks of treatment, both on nicotine and placebo (p < 0.05/p < 0.01). The results of our study thus do not indicate that nicotine applied in the form of dermal plasters is of any significance in the treatment of memory deficits in patient with Alzheimer's disease.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://dx.doi.org/10.1159/000106852ae974a485f413a2113503eed53cd6c53
10.1159/000106852
Scopus Count
Collections
Related articles
- Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.
- Authors: White HK, Levin ED
- Issue date: 1999 Apr
- Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.
- Authors: Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR
- Issue date: 1995 Jun-Jul
- Effects of nicotine nasal spray on cognitive function in schizophrenia.
- Authors: Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A
- Issue date: 2006 Mar
- Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.
- Authors: McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED
- Issue date: 2006 Nov
- Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment.
- Authors: White HK, Levin ED
- Issue date: 2004 Feb